Finance

Beta
Lists
CLN:SWX
Clariant AG
CHF 7.30
+0.55%
(+0.040) 1D
Jun 11, 5:30:08 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for CLN...
Open
CHF 7.25
High
CHF 7.42
Low
CHF 7.25
Mkt. cap
2.42B
Avg. vol.
1.04M
Volume
869.42K
Dividend
5.75%
Quarterly dividend
CHF 0.10
Ex-dividend date
Jul 6, 2020
52-wk high
CHF 9.22
52-wk low
CHF 6.55
EPS
-CHF 0.23
Shares outstanding
331.94M
No. of employees
10K
Open
CHF 7.25
High
CHF 7.42
Low
CHF 7.25
Mkt. cap
2.42B
Avg. vol.
1.04M
Volume
869.42K
Dividend
5.75%
Quarterly dividend
CHF 0.10
Ex-dividend date
Jul 6, 2020
52-wk high
CHF 9.22
52-wk low
CHF 6.55
EPS
-CHF 0.23
Shares outstanding
331.94M
No. of employees
10K
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to CLN in the past 3 months
Hold
Buy
2
Hold
4
Sell
1
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CLN in the last 3 months.
Highest
Current CHF 7.30
CHF 11.00 (+50.58%)
Average
CHF 8.38 (+14.75%)
Lowest
CHF 6.00 (-17.86%)
News stories
From sources across the web
Profile
Clariant AG is a Swiss multinational speciality chemical company, formed in 1995 as a spin-off from Sandoz. Headquartered in Muttenz, Switzerland, the public company encompasses 68 subsidiaries in 36 countries. Major manufacturing sites are located in Europe, North America, South America, China, and India. In 2025, sales from continuing operations were 3.915 billion CHF. European and Middle East markets accounted for 42%, Asia-Pacific for 29%, North America and Latin America for 29% of sales in 2025. EBITDA in 2025 was 643 million CHF. Headquarters are officially in Muttenz, but most global functions are officed in a dedicated corporate center in nearby Pratteln, both near Basel, Switzerland. Clariant's three business units are: Care Chemicals, Adsorbents & Additives and Catalysts. Conrad Keijzer has been Clariant's CEO since 1 January 2021. Wikipedia
About Clariant AG
CEOConrad Keijzer
Employees10K
Founded1995
Headquarters-
SectorSpeciality chemicals
Websiteclariant.com
Last report
May 8, 2026
Fiscal period
Q1 2026
EPS / Est. (CHF)
- / -
Revenue / Est. (CHF)
918.00M / 1.02B
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
990.50M
990.50M
967.00M
967.00M
Cost of goods sold
721.50M
721.50M
625.50M
625.50M
Cost of revenue
721.50M
721.50M
625.50M
625.50M
Research and development expenses
35.50M
35.50M
25.00M
25.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
224.00M
224.00M
134.50M
134.50M
Operating expense
259.50M
259.50M
159.50M
159.50M
Total operating expenses
981.00M
981.00M
785.00M
785.00M
Operating income
9.50M
9.50M
182.00M
182.00M
Other non operating income
-
-
-3.00M
-3.00M
EBT including unusual items
45.00M
45.00M
-22.00M
-22.00M
EBT excluding unusual items
-4.00M
-4.00M
184.50M
184.50M
Income tax expense
23.00M
23.00M
20.50M
20.50M
Effective tax rate
51.11%
51.11%
-93.18%
-93.18%
Other operating expenses
-
-
-
-
Net income
13.00M
13.00M
-50.50M
-50.50M
Net profit margin
1.31%
1.31%
-5.22%
-5.22%
Earnings per share
-
-
-
-
Interest and investment income
4.00M
4.00M
1.50M
1.50M
Interest expense
-28.00M
-28.00M
-4.00M
-4.00M
Net interest expenses
-24.00M
-24.00M
-2.50M
-2.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
59.50M
59.50M
235.00M
235.00M
Gain or loss from assets sale
-
-
-1.00M
-1.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer